BWAY vs. BSX
BWAY (BrainsWay Ltd.) and BSX (Boston Scientific Corporation) are both stocks. Both operate in the Medical Devices industry within the Healthcare sector. Over the past 5 years, BWAY returned 19.75%/yr vs 3.05%/yr for BSX. At a 0.16 correlation, their price movements are largely independent.
Performance
BWAY vs. BSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BWAY achieves a 50.05% return, which is significantly higher than BSX's -48.77% return.
BWAY
- 1D
- 1.64%
- 1M
- -13.09%
- YTD
- 50.05%
- 6M
- 66.61%
- 1Y
- 172.85%
- 3Y*
- 145.45%
- 5Y*
- 19.75%
- 10Y*
- —
BSX
- 1D
- 2.43%
- 1M
- -12.74%
- YTD
- -48.77%
- 6M
- -50.01%
- 1Y
- -52.31%
- 3Y*
- -1.68%
- 5Y*
- 3.05%
- 10Y*
- 7.94%
BWAY vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
BWAY BrainsWay Ltd. | 50.05% | 101.70% | 45.52% | 162.35% | -67.92% | 2.12% | -22.67% | -12.08% |
BSX Boston Scientific Corporation | -48.77% | 6.75% | 54.51% | 24.94% | 8.92% | 18.16% | -20.50% | 29.53% |
Correlation
The correlation between BWAY and BSX is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Apr 18, 2019 | 0.16 |
Fundamentals
BWAY:
$272.32M
BSX:
$73.03B
BWAY:
$0.30
BSX:
$2.38
BWAY:
46.88
BSX:
20.55
BWAY:
0.13
BSX:
0.46
BWAY:
7.35
BSX:
3.54
BWAY:
3.59
BSX:
2.82
BWAY:
$56.22M
BSX:
$20.62B
BWAY:
$42.45M
BSX:
$14.52B
BWAY:
$12.57M
BSX:
$4.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BWAY vs. BSX — Risk / Return Rank
BWAY
BSX
BWAY vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BrainsWay Ltd. (BWAY) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BWAY | BSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +4.82 | ||
| Sortino ratioReturn per unit of downside risk | +6.13 | ||
| Omega ratioGain probability vs. loss probability | 1.46 | 0.67 | +0.79 |
| Calmar ratioReturn relative to maximum drawdown | 9.52 | -0.94 | +10.46 |
| Martin ratioReturn relative to average drawdown | 24.23 | -2.11 | +26.34 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BWAY | BSX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.31 | -1.51 | +4.82 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.32 | 0.12 | +0.20 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.29 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.23 | 0.20 | +0.03 |
Drawdowns
BWAY vs. BSX - Drawdown Comparison
The maximum BWAY drawdown since its inception was -88.14%, roughly equal to the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for BWAY and BSX.
Loading charts...
Drawdown Indicators
| BWAY | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -88.14% | -89.15% | +1.01% |
Max Drawdown (1Y)Largest decline over 1 year | -18.27% | -55.91% | +37.64% |
Max Drawdown (3Y)Largest decline over 3 years | -36.33% | -55.91% | +19.58% |
Max Drawdown (5Y)Largest decline over 5 years | -87.44% | -55.91% | -31.53% |
Max Drawdown (10Y)Largest decline over 10 years | — | -55.91% | — |
Current DrawdownCurrent decline from peak | -16.89% | -54.83% | +37.94% |
Average DrawdownAverage peak-to-trough decline | -37.11% | -38.75% | +1.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.17% | 24.80% | -17.63% |
Volatility
BWAY vs. BSX - Volatility Comparison
The current volatility for BrainsWay Ltd. (BWAY) is 13.94%, while Boston Scientific Corporation (BSX) has a volatility of 16.49%. This indicates that BWAY experiences smaller price fluctuations and is considered to be less risky than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BWAY | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.94% | 16.49% | -2.55% |
Volatility (6M)Calculated over the trailing 6-month period | 39.25% | 32.92% | +6.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 52.60% | 34.73% | +17.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 62.14% | 25.67% | +36.47% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 61.53% | 27.29% | +34.24% |
Dividends
BWAY vs. BSX - Dividend Comparison
Neither BWAY nor BSX has paid dividends to shareholders.
Financials
BWAY vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between BrainsWay Ltd. and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BWAY vs. BSX - Profitability Comparison
BWAY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, BrainsWay Ltd. reported a gross profit of 11.68M and revenue of 15.53M. Therefore, the gross margin over that period was 75.2%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.
BWAY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, BrainsWay Ltd. reported an operating income of 2.01M and revenue of 15.53M, resulting in an operating margin of 12.9%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.
BWAY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, BrainsWay Ltd. reported a net income of 2.29M and revenue of 15.53M, resulting in a net margin of 14.7%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.
Frequently Asked Questions
BWAY and BSX have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BSX has higher volatility (16.49%) compared to BWAY (13.94%). In terms of maximum drawdown, BWAY dropped -88.14% vs BSX's -89.15%.
BWAY currently has the higher Sharpe Ratio (3.31 vs -1.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BWAY and BSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer